Skip to content
Open access

Altered serum vitamin profiles and a PCOS-specific vitamin A–DHEAS association: a three-group case-control study

Oct 2026 · BMC Women's Health · 0 citations

TL;DR

The findings indicate that altered vitamin status is part of the endocrine-metabolic phenotype of PCOS, and that vitamin A adds incremental diagnostic information beyond conventional androgens, but the diagnostic models remain exploratory and require external validation in independent cohorts before clinical application.

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder affecting reproductive-aged women. While individual micronutrients have been investigated, the integrated multi-vitamin landscape and its relationship with hyperandrogenism remain incompletely understood. This study aimed to characterize serum vitamin profiles via liquid chromatography-tandem mass spectrometry (LC-MS/MS) and explore their associations with androgen levels across a three-arm cohort. Nine vitamins and three androgens were quantified via LC-MS/MS in 184 women: healthy controls (HC, n  = 61), women with PCOS ( n  = 66), and non-PCOS infertile women (NPI, n  = 57). Between-group differences were adjusted for age and body mass index (BMI). The vitamin A–DHEAS association was formally tested using interaction regression and Fisher’s r -to- z tests. Diagnostic performance was evaluated using nested logistic regression with leave-one-out cross-validation. After adjustment, PCOS was associated with elevated vitamin A and lower vitamin E, B 1 , and 25(OH)D 2 relative to HC (all p  < 0.001, FDR q  < 0.05). Vitamin A correlated positively with DHEAS specifically in PCOS ( r  = 0.394, p  = 0.001), but not in HC ( r  = − 0.007) or NPI ( r  = 0.021); interaction regression ( β  = 2.600, p  = 0.005) and Fisher’s r -to- z tests ( p  = 0.020 − 0.033) confirmed this group difference. Adding vitamin A to a testosterone-based model improved the AUC from 0.823 to 0.877 for distinguishing PCOS from non-PCOS (DeLong p  = 0.035). This LC-MS/MS study reveals distinct serum vitamin profiles in women with PCOS, including a statistically supported PCOS-specific vitamin A–DHEAS association. These findings indicate that altered vitamin status is part of the endocrine-metabolic phenotype of PCOS, and that vitamin A adds incremental diagnostic information beyond conventional androgens. However, the diagnostic models remain exploratory and require external validation in independent cohorts before clinical application.

Read PDF

Similar papers

Open access Sep 2026

Relationship between Gonadotropin Hormones, Body Mass Index, and Vitamin D Status in Women with Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder that is linked to physiological and reproductive abnormalities. The present investigation was aimed at assessing the association between serum vitamin D, body mass index (BMI), and gonadotropin hormones in women with PCOS and also comparison of these bi...

Lina Mussa Kadhim, Ahlam Hameed, Reyam Moeen Abed · 0 citations
Open access Oct 2026

Association between Diet Quality Index-International and the odds of polycystic ovary syndrome: a case–control study

Background Polycystic ovary syndrome (PCOS) is the most common endocrine-metabolic disorder in women of reproductive age, associated with reproductive, metabolic, and psychological complications. Given the role of lifestyle factors in the pathophysiology of PCOS, dietary patterns have gained attention as modifiable det...

P. Ramaiah, I. Nomani, H. Asfour et al. · 0 citations
Open access Oct 2026

Assessment of serum vitamin D and testosterone levels in women with polycystic ovary syndrome in Babylon Province, Iraq: a case–control study

Introduction: Polycystic ovary syndrome (PCOS) is one of the most frequent endocrine and metabolic disorders of women of reproductive age and is characterized by androgen excess, ovulatory dysfunction and polycystic ovarian morphology, frequently accompanied by insulin resistance and excess adiposity. Vitamin D and cal...

S. A. Naser, Ali Kareem Hameed, Ali Moojid Fadheel · 0 citations
Open access Oct 2026

Serum Interleukin-33 Levels and Their Association with Insulin Resistance and Hormonal Alterations in Women with Polycystic Ovary Syndrome: A Case–Control Study

Background: Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder associated with metabolic imbalances and chronic inflammation. Interleukin-33 (IL-33) has been suggested as a biomarker for inflammation in a number of diseases. Aim of this study: To assess serum IL-33 levels in women with PCOS compared...

Israa Jafar · 0 citations
Open access Oct 2026

Diagnostic and endocrine-metabolic significance of serum kallistatin and vasorin in women with polycystic ovary syndrome from Southern Iraq

Objective: Polycystic ovary syndrome (PCOS) is a common endocrine disorder with heterogeneous metabolic and reproductive features. Novel circulating biomarkers may improve phenotypic characterization. This study aimed to compare serum kallistatin and vasorin levels between women with PCOS and healthy controls and to ex...

T. al-Saady, M. Maatoq, W. Mohmmed · 0 citations
Open access Oct 2026

Vitamin D3 Supplementation Status and Its Association with Serum Omentin-1, Glycemic Control, and Insulin Resistance in Women with Polycystic Ovary Syndrome: A Cross-Sectional Study

Background: Polycystic ovary syndrome (PCOS) is a metabolic and endocrine disorder associated with obesity, adipokine dysregulation, insulin resistance, and subfertility. Omentin-1 is an adipokine with anti-inflammatory and insulin-sensitizing properties. Aims: To evaluate the association of vitamin D3 supplementation...

Zainab Haitham, A. Almulathanon · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.